Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
about
Sarcopenia and Physical Inactivity in Patients With Chronic Kidney DiseaseUremic myopathy: is oxidative stress implicated in muscle dysfunction in uremia?Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.Plasma levels of the pro-inflammatory protein S100A12 (EN-RAGE) are associated with muscle and fat mass in hemodialysis patients: a cross-sectional study.The Effect of Interdialytic Combined Resistance and Aerobic Exercise Training on Health Related Outcomes in Chronic Hemodialysis Patients: The Tunisian Randomized Controlled StudyComparative associations of muscle mass and muscle strength with mortality in dialysis patients.Decrease in urinary creatinine excretion in early stage chronic kidney disease.Mechanisms of muscle wasting in chronic kidney diseaseCirculating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survivalEffect of a low-protein diet supplemented with ketoacids on skeletal muscle atrophy and autophagy in rats with type 2 diabetic nephropathyStrategies to improve physical activity by exercise training in patients with chronic kidney disease.Circulating 20S proteasome is independently associated with abdominal muscle mass in hemodialysis patients.Intradialytic exercise programs for hemodialysis patientsDecreased miR-29 suppresses myogenesis in CKD.Body composition and survival in dialysis patients: results from an international cohort study.Aerobic training during hemodialysis improves body composition, muscle function, physical performance, and quality of life in chronic kidney disease patientsSarcopenia: a major challenge in elderly patients with end-stage renal disease.Influence of megestrol acetate on nutrition, inflammation and quality of life in dialysis patientsIs handgrip strength and key pinch measurement related with biochemical parameters of nutrition in peritoneal dialysis patients?Effect of a low-protein diet supplemented with keto-acids on autophagy and inflammation in 5/6 nephrectomized rats.The role of the inspiratory muscle weakness in functional capacity in hemodialysis patients.Comparison analysis of nutritional scores for serial monitoring of nutritional status in hemodialysis patientsActivation of caspase-3 in the skeletal muscle during haemodialysis.IGF-1 and survival in ESRD.Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.Use of handgrip strength in the assessment of the muscle function of chronic kidney disease patients on dialysis: a systematic review.Muscle wasting from kidney failure-a model for catabolic conditions.Sarcopenia in solid organ transplantation.Effect of progressive resistance training on measures of skeletal muscle hypertrophy, muscular strength and health-related quality of life in patients with chronic kidney disease: a systematic review and meta-analysis.Physiological benefits of exercise in pre-dialysis chronic kidney disease.Pros and cons of body mass index as a nutritional and risk assessment tool in dialysis patients.Differential control of muscle mass in type 1 and type 2 diabetes mellitus.Muscle wasting in chronic kidney disease.Sarcopenic Obesity Definitions by Body Composition and Mortality in the Hemodialysis Patients.Chronic kidney disease-related physical frailty and cognitive impairment: a systemic review.Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass.Screening for muscle loss in patients established on peritoneal dialysis using bioimpedance.Vitamin D, a modulator of musculoskeletal health in chronic kidney disease.Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1.The Effect of Resistance Exercise on Inflammatory and Myogenic Markers in Patients with Chronic Kidney Disease.
P2860
Q26738457-18114DFE-141F-4D8D-8C7D-96CEF0C4AD84Q28084066-23841EDC-7369-40A0-989C-71003A3D856BQ30427552-490B00BA-A632-49DE-A3A8-BC0D0542B47EQ33723012-405D51A7-E6C5-40C6-A94A-BBD01B76278DQ33741301-697B353A-25E7-4608-9FDF-D2368DA71686Q34292906-D4D5A140-3F4D-473B-BB33-456CD60E8E59Q34523616-97CB70D1-D374-4C25-98E2-09623E41EA4AQ34723810-8BDB48B0-C701-4D00-981E-9DEC09BF9C32Q34926791-4DD51809-E585-469D-AFCB-9B43AB7B3DCCQ35058589-88147B18-E4D8-4224-B359-E0AEDA96D4A1Q35185737-0C2AEA38-B817-4C0A-9648-96D2869779DEQ35214455-BB601FEC-FBDE-4E60-B771-E6E26C66F821Q35546244-938A8CFA-601C-41C4-9840-C4D9A9E6CF54Q35595507-A9DA2AA9-FA09-4D1A-B045-2CB5C5ACE27BQ35611214-200F0F91-2DCB-40A1-BD3E-856E46A8C0CEQ35789916-2769A679-408D-4E86-A4CE-9FAC5619BC82Q35875692-680AF3CD-7B13-450C-B7D0-74CB645357F2Q36107155-D710FD9C-6B64-4E5A-807B-B545546EB8B3Q36110999-B3C9D7E9-F36A-40D2-A932-E6D4FE6E607AQ36227351-23E6DCF3-41CA-4888-9B97-11595CC095FDQ36302238-9F80D6B4-AE9F-4C59-884C-26CE401A4C69Q36652791-E500AC40-E358-4EEC-9DEA-7097E1092DCFQ37098455-85F6F99A-4D72-43A4-B2E2-8C587C1C1227Q37426934-2FEB1A2F-700F-499D-BEE3-5D46B4FDED52Q37456616-A66CAAFF-CB6E-4148-BC8F-05A97C011E8BQ37780033-8F31886B-2BB4-43D1-8539-F3D19D95DABBQ38122986-6B2CC249-45FC-495F-B392-27CD17AD4B8DQ38188425-47EF8992-7C9D-46C9-A654-07A8AABBC62DQ38201664-458F0064-3414-46F6-8ACB-47A8FBC8C980Q38217752-6ED761F4-2161-4C33-8EE8-D1A1C4688A77Q38236547-19B9CB00-776D-4D11-BEC1-C8FF930E6D32Q38532367-F273EF90-899E-4E1E-8C4B-8902631A0B21Q38784295-85BDB385-31AA-48F6-8B4F-77739AE2408FQ38791876-6EAC020F-777F-4F20-9876-7D174B7FDADEQ38848257-47008F24-033E-4780-88A1-3F37F65236A3Q39099310-BE620B03-4A01-4802-8CD7-3A4A599ACABEQ39249156-15DF87E6-3D18-43A0-AF58-6EA824629810Q39413414-17409E3E-6D2D-4A70-B653-294E865C7FA5Q39466056-51E20487-EAD1-4970-8FCA-A1DA9DEBDF69Q40095248-C951ED7B-BAF8-4B93-8BDF-5F13AC98BD3B
P2860
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Muscle atrophy, inflammation a ...... d prevalent dialysis patients.
@en
Muscle atrophy, inflammation a ...... d prevalent dialysis patients.
@nl
type
label
Muscle atrophy, inflammation a ...... d prevalent dialysis patients.
@en
Muscle atrophy, inflammation a ...... d prevalent dialysis patients.
@nl
prefLabel
Muscle atrophy, inflammation a ...... d prevalent dialysis patients.
@en
Muscle atrophy, inflammation a ...... d prevalent dialysis patients.
@nl
P2093
P50
P1433
P1476
Muscle atrophy, inflammation a ...... d prevalent dialysis patients.
@en
P2093
Jonas Axelsson
Michal Chmielewski
Mohamed E Suliman
Peter Bárány
Sunna Snaedal
P304
P356
10.1016/J.CLNU.2008.04.007
P577
2008-06-06T00:00:00Z